Gene · 4050
Papers2,481
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,481
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Liver-eye axis in metabolic syndrome: integrated evidence from mendelian randomization, single-cell sequencing, and clinical sample validation. | Front Endocrinol (Lausanne) | 2026 | 42780180 | PubTator, text mining | PubMed |
| Youthful systemic factors restore aged liver regeneration through LTβ-driven hepatocyte reprogramming. | J Hepatol | 2026 | 42772698 | PubTator, text mining | PubMed |
| Stratifying lung adenocarcinoma: a novel prognostic model based on mitochondrial outer membrane permeabilization activity. | 3 Biotech | 2026 | 42745950 | PubTator, text mining | PubMed |
| Immune dysregulation and stem-like CD8+ T cell enrichment in type 1 diabetes pancreatic lymph nodes. | J Clin Invest | 2026 | 42741944 | PubTator, text mining | PubMed |
| Identification of NETs and inflammation-related prognostic genes in breast cancer and PCR experimental validation. | Front Genet | 2026 | 42695096 | PubTator, text mining | PubMed |
| Single-cell transcriptomic profile unveils distinct immune ecosystems in alcohol- and nonalcohol-associated hepatocellular carcinoma. | Front Immunol | 2026 | 42682632 | PubTator, text mining | PubMed |
| Combination antagonism of TNF superfamily signaling for T cell immunosuppression. | Front Immunol | 2026 | 42564165 | PubTator, text mining | PubMed |
| Exploring LTB-mediated T cell differentiation as a prognostic marker in triple-negative breast cancer. | Breast Cancer Res | 2026 | 42381077 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis identifies a tumor-enriched GIMAP7⁺ CD4⁺ naïve T cell population with a unique immunoregulatory state in lung adenocarcinoma. | Funct Integr Genomics | 2026 | 42371181 | PubTator, text mining | PubMed |
| Decoding isonicotinylation-associated patterns in neutrophil chronic obstructive pulmonary disease: evidence from integrative bioinformatic-driven multi-omics and in vitro validation. | Front Physiol | 2026 | 42344274 | PubTator, text mining | PubMed |
| Interaction and Flavor Metabolic Function of Microbiota During Fermentation of Pigskin Through Bioaugmentation with Latilactobacillus sakei. | Molecules | 2026 | 42280192 | PubTator, text mining | PubMed |
| Ligand-Receptor Interaction Combined with Histopathology Improves Glioma Prognostic Model. | Biomedicines | 2026 | 42193434 | PubTator, text mining | PubMed |
| TCF1+CD4+ T cells and microglia co-orchestrate tertiary lymphoid structures to enhance prognosis and immunotherapy in non-small cell lung cancer with brain metastases. | EBioMedicine | 2026 | 42085932 | PubTator, text mining | PubMed |
| Lymphotoxin-beta receptor controls the development of chronic pain. | Cell Rep | 2026 | 42012978 | PubTator, text mining | PubMed |
| Aberrant immune regulation and enrichment of stem-like CD8+ T cells in the pancreatic lymph node during type 1 diabetes development. | bioRxiv | 2026 | 41959012 | PubTator, text mining | PubMed |
| The CD4+ T cell population partners with Tpex CD8+ T cells to mediate antitumor immunity in the tumor microenvironment. | Nat Commun | 2026 | 41904165 | PubTator, text mining | PubMed |
| In Silico Design and Subsequent Expression of Human Papillomavirus-16 and -18 L1 Vaccine Antigens in Broccoli. | Vaccines (Basel) | 2026 | 41893797 | PubTator, text mining | PubMed |
| Therapeutic strategy for cervical gastric-type adenocarcinoma by targeting CLU to relieve CLU-associated stress and sensitize chemotherapy. | Precis Clin Med | 2026 | 41878236 | PubTator, text mining | PubMed |
| Spatial transcriptomics from pancreas and local draining lymph node tissue reveals a lymphotoxin-β signature in human type 1 diabetes. | Cell Rep | 2026 | 41875135 | PubTator, text mining | PubMed |
| KLRG1 defines a distinct tumor-infiltrating granzyme K+ CD8 + T cell population. | J Cancer Res Clin Oncol | 2026 | 41857425 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4050/papers